Abstract
Get full access to this article
View all access options for this article.
References
1.
Wilkinson
DS
,
Fregert
S
,
Magnusson
B
et al.. Terminology of contact dermatitis . Acta Derm Venereol (Stockh) , 1970 ; 50 : 287 –292 .
2.
Sugai
T.
Contact dermatitis syndrome and unusual skin manifestations . Skin Res , 1988 ; 30 (Suppl 5 ): 8 –17 .
3.
Lachapelle
J
,
Maibach
H.
The spectrum of diseases for which patch testing is recommended . In:
Lachapelle
J
,
Maibach
H
Patch Testing and Prick Testing . 2nd ed. Berlin, Germany : Springer ; 2009 : 7 –32 .
4.European Medicines Agency recommends revocation of marketing authorisations for bufexamac . April 22, 2010. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2010/04/WC500089623.pdf#search=’eu,%20bufexamac’. Accessed April 3 , 2012
5.Revocation of marketing of non-steroidal agents, bufexamac [in Japanese] (Ministry of Health, Labour and Walfare Web site) . May 11, 2011. Available at: http://www.mhlw.go.jp/stf/shingi/2r9852000000jff9-att/2r9852000000jfov.pdf. Accessed April 3 , 2012